iPharma Retatrutide 30mg Pre-Filled Pen

Next-Generation Metabolic Research Advanced Triple-Action Peptide

Retatrutide is a triple-action receptor agonist researched for its interaction with GIP, GLP-1, and glucagon receptors. Supplied in a convenient 30mg pen format, Retatrutide represents one of the latest advancements in metabolic and wellness-focused peptide research.

By combining three metabolic pathways into a single formulation, Retatrutide has gained significant attention in studies involving appetite regulation, energy balance, and metabolic wellness support.

Features & Benefits

30mg Retatrutide peptide formulation

Convenient injectable pen format

Triple-action GIP, GLP-1, and glucagon receptor research

Investigated for metabolic wellness pathways

Research interest in appetite and satiety support

Studied for energy-expenditure and metabolic regulation pathways

Associated with blood sugar and metabolic-balance research

Widely recognised in advanced metabolic investigations

How Retatrutide Works

Retatrutide is researched for its interaction with:

GIP receptors

GLP-1 receptors

Glucagon receptors

By adding glucagon receptor activity to the established GIP/GLP-1 pathway approach, Retatrutide is studied for its potential role in both appetite control and energy-expenditure support.

Early investigational studies have shown promising findings in metabolic and wellness-related research environments.

Handling & Use

For research use only.

Handle using sterile laboratory procedures.

Store according to packaging instructions.

Use only in controlled research environments.